SCHEMBL6983048

SCHEMBL6983048

N#Cc1ccc(CNC(=O)N2CCCc3cccc(NS(=O)(=O)c4ccccc4)c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.41
PKM P14618 1/20 0.41
TP53 P04637 3/20 0.40
NR3C1 P04150 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 2/20 0.40
THRB P10828 1/20 0.40
AR P10275 1/20 0.40
METAP2 P50579 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP19A1 P11511 1/20 0.38
CCKBR P32239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985322 0.86 GAA (0.41) PKMTP53NR3C1MAPTLMNA
SCHEMBL6985371 0.84 NR3C1 (0.44) PKMNR3C1LMNAARALDH1A1
SCHEMBL6981761 0.83 LIMK2 (0.40) PKMTP53NR3C1MAPTLMNA
SCHEMBL6980541 0.82 HSD17B10 (0.48) PKMTP53NR3C1MAPTLMNA
SCHEMBL6983044 0.82 NR3C1 (0.58) PKMTP53NR3C1MAPTLMNA
SCHEMBL6984554 0.80 ALDH1A1 (0.44) PKMTP53NR3C1MAPTLMNA
SCHEMBL6982980 0.80 PKM (0.39) PKMTP53NR3C1MAPTLMNA
SCHEMBL7406048 0.80 EEF2K (0.39) PKMTP53NR3C1MAPTLMNA
SCHEMBL6976883 0.80 NR3C1 (0.38) PKMTP53NR3C1MAPTLMNA
SCHEMBL6983505 0.79 NR3C1 (0.42) PKMTP53NR3C1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed